Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives $39.86 Average Price Target from Analysts
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have received a consensus rating of “Buy” from the nine research firms that are covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12-month price […]
Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) have received a consensus rating of “Buy” from the nine research firms that are covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12-month price […]
